Seeking Alpha

Shares of Cytori Therapeutics (CYTX +3.5%) trade up after Maxim Group initiates coverage with a...

Shares of Cytori Therapeutics (CYTX +3.5%) trade up after Maxim Group initiates coverage with a Buy and a $10 price target. CYTX is a stem-cell research firm focused on developing a therapeutic platform that harnesses the power of regenerative cells to treat and cure a multitude of human afflictions using a razor/razor blade model.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs